251 related articles for article (PubMed ID: 27927840)
1. β-Blockers, heart disease and COPD: current controversies and uncertainties.
Baker JG; Wilcox RG
Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
[TBL] [Abstract][Full Text] [Related]
2. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
Rasmussen DB; Lange P; Jensen MT
Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
[TBL] [Abstract][Full Text] [Related]
3. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
4. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
5. Beta-blockers in COPD: time for reappraisal.
Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
[TBL] [Abstract][Full Text] [Related]
6. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
[TBL] [Abstract][Full Text] [Related]
7. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
Glaab T; Weiss T
Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
[TBL] [Abstract][Full Text] [Related]
8. [Beta-blockers and obstructive pulmonary diseases: such an odd couple?].
Grosgurin O; Bria A; Gaspoz JM
Rev Med Suisse; 2006 Jan; 2(50):285-8. PubMed ID: 16503045
[TBL] [Abstract][Full Text] [Related]
9. Can beta-blockers be used for people with COPD?
Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
[TBL] [Abstract][Full Text] [Related]
10. Is the use of beta-blockers in COPD still an unresolved dilemma?
Foresi A; Cavigioli G; Signorelli G; Pozzoni MB; Olivieri D
Respiration; 2010; 80(3):177-87. PubMed ID: 20639691
[TBL] [Abstract][Full Text] [Related]
11. Role of beta-blockers in patients with COPD: current perspective.
Malerba M; Montuschi P; Radaeli A; Pirisi M
Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
[TBL] [Abstract][Full Text] [Related]
12. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
[TBL] [Abstract][Full Text] [Related]
13. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
14. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
15. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
16. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
[TBL] [Abstract][Full Text] [Related]
17. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
18. [Possibilities and limitations of the use of beta-blockers in patients with cardiovascular disease and chronic obstructive pulmonary disease].
Karoli NA; Rebrov AP
Kardiologiia; 2021 Oct; 61(10):89-98. PubMed ID: 34763643
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of the combination of inhaled beta2-agonists and beta-blockers in COPD patients with cardiovascular disease.
Petta V; Perlikos F; Loukides S; Bakakos P; Chalkias A; Iacovidou N; Xanthos T; Tsekoura D; Hillas G
Heart Fail Rev; 2017 Nov; 22(6):753-763. PubMed ID: 28840400
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
Matera MG; Martuscelli E; Cazzola M
Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]